NCT04233411已完成不适用
The Bioavailability of Mycoprotein
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 12
- 试验地点
- 1
- 主要终点
- Plasma total amino acid concentrations
研究概览
简要总结
To evaluate the bioavailability of mycoprotein, compared with a reference animal based protein, in a dose-response manner.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 40 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Healthy and aged 18-40 y
- •BMI between 18 and 30
排除标准
- •On medication
- •Family history of metabolic disease
- •Diagnosed with any metabolic or cardiovascular conditions
- •BMI < 18 or > 30
研究组 & 干预措施
Milk
Active Comparator
Acute ingestion of 20 g milk protein
干预措施: Mycoprotein ingestion (Other)
20g
Experimental
Acute ingestion of 20 g mycoprotein
干预措施: Mycoprotein ingestion (Other)
40g
Experimental
Acute ingestion of 40 g mycoprotein
干预措施: Mycoprotein ingestion (Other)
60g
Experimental
Acute ingestion of 60 g mycoprotein
干预措施: Mycoprotein ingestion (Other)
80g
Experimental
Acute ingestion of 60 g mycoprotein
干预措施: Mycoprotein ingestion (Other)
结局指标
主要结局
Plasma total amino acid concentrations
时间窗: 4 hours
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Mycophenolate Mofetil Tablets Under Fasting ConditionsHealthyNCT00907907Teva Pharmaceuticals USA40
已完成
1 期
Mycophenolate Mofetil Tablets Under Fed ConditionsHealthyNCT00908128Teva Pharmaceuticals USA40
已完成
不适用
Bioavailability Study of Two Mesalamine 4 gm/60 ml Rectal Enema FormulationsHealthyNCT00802451Padagis LLC48
已完成
1 期
Mesalamine 4 gm/60 mL Rectal EnemaHealthyNCT00840203Teva Pharmaceuticals USA72
已完成
1 期
A Study Comparing PF-05089771 TS Capsule To PF-05089771 TS Oral Dispersion In The Fasted StatePainNCT01690351Pfizer12